Search research articles
Contact Us
Filters
Showing results (31-40 of 47) with videos related to
Page
of 5
Sort By:
Journal of Clinical Psychopharmacology
|
August 5, 1998
Olanzapine-induced reversible priaprism: a case report
J M Deirmenjian, S M Erhart, D A Wirshing, et al.
Psychopharmacology Bulletin
|
January 1, 1991
Plasma fluphenazine levels and clinical response in newly admitted schizophrenic patients
T Van Putten, M Aravagiri, S R Marder, et al.
Psychiatry Research
|
February 1, 1989
Comparison of electromechanical measures and observer ratings of tardive dyskinesia
G Bartzokis, W C Wirshing, M A Hill, et al.
Psychopharmacology Bulletin
|
January 1, 1991
Early prediction of relapse in schizophrenia: an application of receiver operating characteristic (ROC) methods
S R Marder, J Mintz, T Van Putten, et al.
The American Journal of Psychiatry
|
September 15, 1999
Risperidone in treatment-refractory schizophrenia
D A Wirshing, B D Marshall, M F Green, et al.
Biological Psychiatry
|
October 20, 1998
Tardive dyskinesia and serum iron indices
D A Wirshing, G Bartzokis, J M Pierre, et al.
The American Journal of Psychiatry
|
November 1, 1992
Technique for training schizophrenic patients in illness self-management: a controlled trial
T A Eckman, W C Wirshing, S R Marder, et al.
The Journal of Clinical Psychiatry
|
July 13, 1999
Novel antipsychotics: comparison of weight gain liabilities
D A Wirshing, W C Wirshing, L Kysar, et al.
Archives of General Psychiatry
|
April 1, 1994
Fluphenazine vs placebo supplementation for prodromal signs of relapse in schizophrenia
S R Marder, W C Wirshing, T Van Putten, et al.
Biological Psychiatry
|
November 3, 1998
Risperidone vs. haloperidol on reaction time, manual dexterity, and motor learning in treatment-resistant schizophrenia patients
R S Kern, M F Green, B D Marshall, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 47) with videos related to
Sort By:
Page
of 5
Journal of Clinical Psychopharmacology
|
August 5, 1998
Olanzapine-induced reversible priaprism: a case report
J M Deirmenjian, S M Erhart, D A Wirshing, et al.
Psychopharmacology Bulletin
|
January 1, 1991
Plasma fluphenazine levels and clinical response in newly admitted schizophrenic patients
T Van Putten, M Aravagiri, S R Marder, et al.
Psychiatry Research
|
February 1, 1989
Comparison of electromechanical measures and observer ratings of tardive dyskinesia
G Bartzokis, W C Wirshing, M A Hill, et al.
Psychopharmacology Bulletin
|
January 1, 1991
Early prediction of relapse in schizophrenia: an application of receiver operating characteristic (ROC) methods
S R Marder, J Mintz, T Van Putten, et al.
The American Journal of Psychiatry
|
September 15, 1999
Risperidone in treatment-refractory schizophrenia
D A Wirshing, B D Marshall, M F Green, et al.
Biological Psychiatry
|
October 20, 1998
Tardive dyskinesia and serum iron indices
D A Wirshing, G Bartzokis, J M Pierre, et al.
The American Journal of Psychiatry
|
November 1, 1992
Technique for training schizophrenic patients in illness self-management: a controlled trial
T A Eckman, W C Wirshing, S R Marder, et al.
The Journal of Clinical Psychiatry
|
July 13, 1999
Novel antipsychotics: comparison of weight gain liabilities
D A Wirshing, W C Wirshing, L Kysar, et al.
Archives of General Psychiatry
|
April 1, 1994
Fluphenazine vs placebo supplementation for prodromal signs of relapse in schizophrenia
S R Marder, W C Wirshing, T Van Putten, et al.
Biological Psychiatry
|
November 3, 1998
Risperidone vs. haloperidol on reaction time, manual dexterity, and motor learning in treatment-resistant schizophrenia patients
R S Kern, M F Green, B D Marshall, et al.
Page
of 5